Avidity Partners Management LP Exelixis, Inc. Transaction History

Avidity Partners Management LP

  • $1.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$18.39 - $24.8 $14.1 Million - $19.1 Million
-769,200 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$20.67 - $26.94 $39.8 Million - $51.9 Million
-1,924,870 Reduced 71.45%
769,200 $18.8 Million
Q2 2020

Aug 14, 2020
BUY
$16.46 - $27.42 $26.5 Million - $44.1 Million
1,608,070 Added 148.07%
2,694,070 $64 Million
Q1 2020

Jun 17, 2020
BUY
$14.46 - $21.8 $15.7 Million - $23.7 Million
1,086,000 New
1,086,000 $18.7 Million

Others Institutions Holding EXEL

# of Institutions
501
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email